A Trial to Investigate the Efficacy and Safety of Ultra-Low Dose HRT for Treatment of Menopausal Symptoms.

Trial Profile

A Trial to Investigate the Efficacy and Safety of Ultra-Low Dose HRT for Treatment of Menopausal Symptoms.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Estradiol (Primary) ; Norethisterone (Primary)
  • Indications Hot flashes; Menopausal syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms CHOICE
  • Most Recent Events

    • 12 May 2009 Actual patient number (576) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top